Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. detect disease biomarkers
Show results for

Refine by
Date

  • Older

Detect Disease Biomarkers Articles & Analysis

30 news found

SpinTech CEO Presents STAGE at MedTech Strategist Innovation San Francisco 2021

SpinTech CEO Presents STAGE at MedTech Strategist Innovation San Francisco 2021

Ward Detwiler, our President & CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021. ...

BySpinTech, Inc.


Independent Clinical Study Shows Seravue® Has High Sensitivity And Specificity For The Detection Of Liver Cancer In Nafld And Related Cirrhotic Patients

Independent Clinical Study Shows Seravue® Has High Sensitivity And Specificity For The Detection Of Liver Cancer In Nafld And Related Cirrhotic Patients

This study focused on the performance of Seravue and the LC-SPIK biomarker in detecting hepatocellular carcinoma (HCC) in a pool of nonalcoholic fatty liver disease (NAFLD) related cirrhosis patients. Here, LC-SPIK had an AUC of 0.841 and significantly outperformed AFP, the most common biomarker used for HCC ...

ByImCare Biotech, LLC


Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

The discernible differences seem to decline in subjects with mild cognitive impairment (MCI) or overt Alzheimer’s Disease (AD), independent of age. In the healthy population, the primary differentiating features are micro hand gestures detectable on a wearable, that measured accelerometric data. ...

ByAltoida, Inc.


Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

The discernible differences seem to decline in subjects with mild cognitive impairment (MCI) or overt Alzheimer’s Disease (AD), independent of age. In the healthy population, the primary differentiating features are micro hand gestures detectable on a wearable, that measured accelerometric data. ...

ByAltoida, Inc.


PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results

PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) and Veris Health Inc. (“Veris”), and ...

ByPAVmed Inc.


Creative Proteomics Cytokine Unveils Disease Cytokine Assays for Disease Diagnosis

Creative Proteomics Cytokine Unveils Disease Cytokine Assays for Disease Diagnosis

Biomarker detection can provide insight into the mechanism of action or resistance of new drugs in disease models. Creative Proteomics can provide detection services for cytokines and biomarkers for the majority of pharmaceutical R&D personnel. Its Cytokine division has complete infrastructure and ...

ByCreative Proteomics


Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF)

Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF)

“The ADDF created the Diagnostics Accelerator to support research into promising biomarkers that will play a crucial role in research, diagnosis, and treatment of Alzheimer’s disease. ...

ByOptina Diagnostics


Nanox Announces Issuance of American Medical Association New Category III CPT® Code for Its Coronary Artery Calcium Population Health Solution

Nanox Announces Issuance of American Medical Association New Category III CPT® Code for Its Coronary Artery Calcium Population Health Solution

CAC is a recognized vital biomarker for detection of cardiovascular disease. Nanox.AI believes that early detection and subsequent treatment of cardiovascular disease has the potential to significantly decrease the morbidity and mortality of this highly prevalent condition. ...

ByNano-X Imaging Ltd.


Novosanis launches Colli-Pee containing UAS Large Volumes, offering a new solution for oncology research

Novosanis launches Colli-Pee containing UAS Large Volumes, offering a new solution for oncology research

Today, Novosanis has launched its novel solution for oncology research applications. Together with our sister company DNA Genotek, we have developed a novel stabilization chemistry, UAS, for the preservation of extracellular vesicle (EV) RNA, and cell-free DNA (cfDNA) in urine, collected with Colli-Pee. Novosanis hereby offers a solution for applications in the field of oncology research and ...

ByNovosanis NV


Winner announcement of EACR & Novosanis Research Grant: Cancer Biomarker Detection in Urine

Winner announcement of EACR & Novosanis Research Grant: Cancer Biomarker Detection in Urine

We are pleased to announce that Dr Barbara Guinn from University of Hull UK is the winner of the EACR & Novosanis Grant for Cancer Biomarker Detection in Urine. The grant awards the most impactful proposal in cancer related research using urine as a sample type, which has shown to be an emerging non-invasive liquid biopsy. For urine sample collection, the Colli-Pee device will be provided by ...

ByNovosanis NV


X-ZELL hMX technology now available for research use

X-ZELL hMX technology now available for research use

X-ZELL’s widely recognised high-gradient magnetic Cell Separator (hMX™) is now available to researchers worldwide. Previously exclusive to X-ZELL, the patented system is part of the company’s single-cell diagnostics platform, which is capable of isolating and visualising individual atypical cells from a small 10mL blood sample. According to X-ZELL’s Head of Engineering ...

ByX-Zell Inc.


X-ZELL launches new Imaging Technology unit

X-ZELL launches new Imaging Technology unit

Award-winning Singaporean start-up, X-ZELL, has announced the formation of a new, interdisciplinary Imaging Technology division. The announcement comes on the back of a new collaboration agreement with Finnish Artificial Intelligence (AI) specialist, Aiforia Technologies, and is part of the ongoing digitisation of X-ZELL’s patented rare cell detection technology. X-ZELL’s modular ...

ByX-Zell Inc.


Novosanis research grant

Novosanis research grant

Research grant of (up to) € 25 000 in support of the most impactful proposal and (up to) 200 Colli-Pee urine collection devices for use with the project. Novosanis is offering a research grant exclusive to EACR members to stimulate innovative research in cancer biomarker detection using urine as a sample type. As urine sampling is easy, quick and non-invasive it has the potential to change ...

ByNovosanis NV


Does volume matter? Impact of collection volumes on detection of biomarkers and HPV DNA in first-void urine

Does volume matter? Impact of collection volumes on detection of biomarkers and HPV DNA in first-void urine

The study by Laura Téblick (University of Antwerp, Belgium) investigated whether varying first-void urine collection volumes, including 4, 10 and 20 mL collected with Colli-Pee, affects the detection of human and viral endpoints (i.e., glyceraldehyde 3-phosphate dehydrogenase (GAPDH), β-actin (ACTB), β-globin (HBB) and Human Papillomavirus (HPV). The results showed that all ...

ByNovosanis NV


The Netherlands started QIAsure Methylation Test implementation trial for triage of HPV positively screened women

The Netherlands started QIAsure Methylation Test implementation trial for triage of HPV positively screened women

The majority of these referrals appear unnecessary because the HPV positive cytology positive tested women often harbor an infection that will not cause high grade disease or cancer, but in fact carry a very low risk for severe disease. ...

BySelf-screen B.V.


Unique Metabolic Signatures Associated with Autism Spectrum Disorder (ASD) Detect More than 50% of individuals with ASD in Children’s Autism Metabolome Project (CAMP)

Unique Metabolic Signatures Associated with Autism Spectrum Disorder (ASD) Detect More than 50% of individuals with ASD in Children’s Autism Metabolome Project (CAMP)

In a paper published online this week in Autism Research, scientists at NeuroPointDX, a division of Stemina Biomarker Discovery, Inc., in collaboration with researchers at the UC Davis MIND Institute and academic and clinical institutions across the country, report new findings from the Children’s Autism Metabolome Project or CAMP. Analysis of blood samples from CAMP, the largest study yet ...

ByNeuroPointDX


Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions

Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions

LC-SCRUM-Asia, a leading cancer genomic screening program, has selected Thermo Fisher Scientific's Ion Torrent Genexus System* and Oncomine Precision Assay*, a pan-cancer panel, to advance precision medicine in Asia. The next-generation sequencing (NGS) solutions will be used in two prospective, observational projects to support the development of future therapeutics and diagnostics for non-small ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Bodyport raises $11.2 million in Series A funding to launch virtual cardiac clinic

Bodyport raises $11.2 million in Series A funding to launch virtual cardiac clinic

Bodyport, the digital health company focused on the detection and management of heart disease, today announced the close of an $11.2 million Series A investment round. ...

ByBodyport Inc.


Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals

Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals

Thermo Fisher Scientific today announced that it has expanded its strategic partnership with Agios Pharmaceuticals by adding the co-development of a second companion diagnostic (CDx) for oncology to their existing agreement. The CDx will leverage the Oncomine Precision Assay, which runs on the new Ion Torrent Genexus System, and will be used globally to identify low-grade glioma (LGG) patients ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Alzheimer’s Drug Discovery Foundation’s diagnostics accelerator announces first digital biomarker research award and data sharing platform

Alzheimer’s Drug Discovery Foundation’s diagnostics accelerator announces first digital biomarker research award and data sharing platform

Lauder, Bill Gates, Jeff Bezos and MacKenzie Bezos, the Dolby family, the Charles and Helen Schwab Foundation, and others to speed up development of biomarkers for early detection of Alzheimer's and related dementias The Alzheimer’s Drug Discovery Foundation (ADDF) today announced five new research investments through its Diagnostics ...

ByHummingbird Diagnostics GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT